메뉴 건너뛰기




Volumn 41, Issue 3, 2016, Pages 204-206

Combined treatment with 131I-MIBG and sunitinib induces remission in a patient with metastatic paraganglioma due to hereditary paraganglioma-pheochromocytoma syndrome from an SDHB mutation

Author keywords

131I MIBG; Paraganglioma; Pheochromocytoma; Sunitinib

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; SUNITINIB; (3 IODOBENZYL)GUANIDINE; INDOLE DERIVATIVE; PYRROLE DERIVATIVE; SDHB PROTEIN, HUMAN; SUCCINATE DEHYDROGENASE;

EID: 84944342532     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0000000000000973     Document Type: Article
Times cited : (8)

References (12)
  • 1
    • 77952777089 scopus 로고    scopus 로고
    • A current review of the etiology, diagnosis and treatment of pediatric pheochromocytoma and paraganglioma
    • Waguespack SG, Rich T, Grubbs E, et al. A current review of the etiology, diagnosis and treatment of pediatric pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2010;95:2023-2037.
    • (2010) J Clin Endocrinol Metab. , vol.95 , pp. 2023-2037
    • Waguespack, S.G.1    Rich, T.2    Grubbs, E.3
  • 2
    • 80755127100 scopus 로고    scopus 로고
    • Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: Significant link to SDHB mutations
    • King KS, Prodanov T, Kantorovich V, et al. Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. J Clin Oncol. 2011; 29:4137-4142.
    • (2011) J Clin Oncol. , vol.29 , pp. 4137-4142
    • King, K.S.1    Prodanov, T.2    Kantorovich, V.3
  • 3
    • 79151480949 scopus 로고    scopus 로고
    • Malignant pheochromocyto-mas and paragangliomas - The importance of a multidisciplinary approach
    • Andersen KF, Altaf R, Krarup-Hansen A, et al. Malignant pheochromocyto-mas and paragangliomas-the importance of a multidisciplinary approach. Cancer Treat Rev. 2011;37:111-119.
    • (2011) Cancer Treat Rev. , vol.37 , pp. 111-119
    • Andersen, K.F.1    Altaf, R.2    Krarup-Hansen, A.3
  • 4
    • 84895924028 scopus 로고    scopus 로고
    • (131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: Systematic review and meta-analysis
    • Van Hulsteijn LT, Niemeijer ND, Dekkers OM, et al. (131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis. Clin Endocrinol (Oxf). 2014;80:487-501.
    • (2014) Clin Endocrinol (Oxf). , vol.80 , pp. 487-501
    • Van Hulsteijn, L.T.1    Niemeijer, N.D.2    Dekkers, O.M.3
  • 5
    • 70249133742 scopus 로고    scopus 로고
    • 131I] metaiodobenzylguanidine therapy for patients with metastatic pheochromo-cytoma and paraganglioma
    • 131I] metaiodobenzylguanidine therapy for patients with metastatic pheochromo-cytoma and paraganglioma. J Clin Oncol. 2009;27:4162-4168.
    • (2009) J Clin Oncol. , vol.27 , pp. 4162-4168
    • Gonias, S.1    Goldsby, R.2    Matthay, K.K.3
  • 6
    • 84868621823 scopus 로고    scopus 로고
    • Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas
    • Ayala-Ramirez M, Chougnet CN, Habra MA, et al. Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas. J Clin Endocrinol Metab. 2012;97:4040-4050.
    • (2012) J Clin Endocrinol Metab. , vol.97 , pp. 4040-4050
    • Ayala-Ramirez, M.1    Chougnet, C.N.2    Ma, H.3
  • 7
    • 84874058676 scopus 로고    scopus 로고
    • Sunitinib for the treatment of metastatic paraganglioma and vasoactive intestinal polypeptide-producing tumor (VIPoma)
    • Bourcier ME, Vinik AI. Sunitinib for the treatment of metastatic paraganglioma and vasoactive intestinal polypeptide-producing tumor (VIPoma). Pancreas. 2013;42:348-352.
    • (2013) Pancreas. , vol.42 , pp. 348-352
    • Bourcier, M.E.1    Vinik, A.I.2
  • 8
    • 84903533733 scopus 로고    scopus 로고
    • Sunitinib for refractory malignant pheo-chromocytoma: Two case reports
    • Hata J, Haga N, Ishibashi K, et al. Sunitinib for refractory malignant pheo-chromocytoma: two case reports. Int Urol Nephrol. 2014;46:1309-1312.
    • (2014) Int Urol Nephrol. , vol.46 , pp. 1309-1312
    • Hata, J.1    Haga, N.2    Ishibashi, K.3
  • 9
    • 58149385799 scopus 로고    scopus 로고
    • Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma
    • Joshua AM, Ezzat S, Asa SL, et al. Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma. J Clin Endocrinol Metab. 2009;94:5-9.
    • (2009) J Clin Endocrinol Metab. , vol.94 , pp. 5-9
    • Joshua, A.M.1    Ezzat, S.2    Asa, S.L.3
  • 12
    • 84947025820 scopus 로고    scopus 로고
    • 177Lu-DOTA0Tyr3]octreotate in combination with RAD001 treatment: Further investigations on tumor metastasis and response in the rat pancreatic CA20948 tumor model
    • 177Lu-DOTA0Tyr3]octreotate in combination with RAD001 treatment: further investigations on tumor metastasis and response in the rat pancreatic CA20948 tumor model. EJNMMI Res. 2014;4:21.
    • (2014) EJNMMI Res. , vol.4 , pp. 21
    • Bison, S.M.1    Pool, S.E.2    Koelewijn, S.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.